Skip to Content
    Call Our 24/7 Helpline 800.272.3900 800.272.3900
    $ Donate Donate GIVE IN HONOR & MEMORY

    News

    News

    The Alzheimer's Association is dedicated to promoting awareness of the latest Alzheimer's research, resources and news. Any news release posted here reflects the knowledge, statistics and position of the Alzheimer's Association at that time. Browse and share the articles below, or sign up for our e-newsletter to stay informed on the global fight against Alzheimer's.

    Featured News Items
    Press releases & statements

    House Passes Bipartisan Alzheimer's Workforce Bill

    The Alzheimer's Association and the Alzheimer's Impact Movement celebrate the passage of the bipartisan Accelerating Access to Dementia & Alzheimer's Provider Training (AADAPT) Act by the U.S. House of Representatives.
    July 21, 2026
    Press releases & statements

    Research Advances from the 2026 Alzheimer's Association International Conference

    The latest scientific advances included new insights into Alzheimer’s blood tests for improving diagnosis in primary care & for predicting future cognitive decline.
    July 15, 2026
    Press releases & statements

    Alzheimer’s Association Welcomes Updated WHO Dementia Risk Reduction Guidelines

    The World Health Organization (WHO) released updated global guidelines that reflect a growing body of evidence on dementia risk reduction, including modifiable risk factors. 
    July 15, 2026
    Press releases & statements

    Blood Test May Help Predict Alzheimer’s Risk a Decade Before Symptoms Appear

    A blood test detecting p-tau217, a protein linked to Alzheimer’s, may help predict cognitive impairment in older adults a decade before symptoms appear.
    July 15, 2026
    Press releases & statements

    Detailed Phase 2 Results From the CELIA Clinical Trial of Tau-Targeting Therapy Diranersen (BIIB080)

    This is the first Phase 2 clinical trial evidence that a drug treatment can remove toxic tau tangles from the brain in people living with early Alzheimer’s disease.
    July 14, 2026
    Press releases & statements

    Topline Results from LiBBY Trial Show THC/CBD Combination Significantly Reduces Agitation for People with Dementia at End of Life

    A new treatment combining THC and CBD significantly reduced agitation in people with late-stage Alzheimer’s and other dementias, as reported at AAIC 2026.
    July 14, 2026
    Search News

    Press Resources

    Access a range of media resources to support your reporting, including downloadable fact sheets, infographics, videos, official statements, and background materials about the Alzheimer’s Association and our mission.

    View Press Resources

    Related quick links

    Speaker Bios

    Maria C. Carrillo, Ph.D.

    Chief Science Officer and Medical Affairs Lead, Alzheimer’s Association

    See Bio

    Robert Egge

    Chief Public Policy Officer, Alzheimer’s Association and President, Alzheimer's Impact Movement

    See Bio

    Heather M. Snyder, Ph.D.

    Senior Vice President, Medical & Scientific Operations

    See Bio

    View All Spokespeople

    Donate Make a Donation
    24/7 Helpline 800.272.3900
    In My Area Local Resources